Evidence map›Paper›PMID 30954315›Full record

ArticleEuropean urology2019

PARP Inhibitors for Advanced Prostate Cancer: Validating Predictive Biomarkers.

Joaquin Mateo, Suzanne Carreira, Johann S de Bono

Abstract readEditorialComment
PubMed Publisher
In one paragraph

Article in European urology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Targeting Polymerase Theta (POLθ) for Cancer Therapy.Cancer treatment and research · 2023
    Review
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Joaquin MateoVall d'Hebron Institute of Oncology and Vall d'Hebron University Hospital, Barcelona, Spain. Electronic address: jmateo@vhio.net.
Suzanne CarreiraThe Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, UK.
Johann S de BonoThe Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Poly(ADP-ribose) Polymerase InhibitorsProstatic Neoplasms, Castration-ResistantAtaxia Telangiectasia Mutated ProteinsBiomarkersBRCA1 ProteinBRCA2 ProteinHumansMaleMutationPhthalazinesPiperazinesAtaxia Telangiectasia Mutated ProteinsATM protein, humanBiomarkersBRCA1 ProteinBRCA1 protein, humanBRCA2 ProteinBRCA2 protein, humanolaparibPhthalazinesPiperazinesPoly(ADP-ribose) Polymerase Inhibitors

Identifiers

PMID30954315

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.